Nufarm share price: what to expect from full-year results

With the company recently revising its full-year earnings (EBITDA), below we take a look at some of the key things investors should be aware of before Nufarm reports its FY19 results.

When will Nufarm release its FY19 results?

Nufarm (ASX: NUF) is set to release its 2019 full-year results to the market on Monday, September 30 – before the market opens.

What is the company’s full-year guidance?

The company faced a challenging first-half in FY19, reporting profits (NPAT) that came in significantly lower than the prior corresponding period. The company also suspended its first-half dividend.

Amongst all this, there remains glimpses of growth, with Nufarm seeing good outcomes across its North America and Latin America business segments, as well as its seed technologies.

Primarily, while the company initially guided full-year 2019 earnings (EBITDA) in the range of A$440m to A$470m, Nufarm has since revised this figure downwards to around A$420m.

On this revised figure, CEO and Managing Director Greg Hunt said:

‘It's been a difficult year, with external headwinds impacting performance in three of our four major markets.’

Mr Hunt added that:

‘We are disappointed the work we have done to mitigate the external challenges has not been enough to achieve the targets we set for the financial year.’

Though the downgrade may be a disappointing development for investors, Nufarm (ASX: NUF) has taken proactive steps to sure up its balance sheet in the meantime.

For example, in August, the company raised A$97.5m through the placement of preference securities to current shareholders and the Sumitomo Chemical Company.

Nufarm share price: the analyst take

Though the Nufarm (ASX: NUF) share price has fallen approximately 22% since January, analysts continue to view the stock optimistically.

According to the Wall Street Journal, of the analysts covering the stock: five rate it a buy, while two rate it overweight. Only four analysts rate it a hold.

Overall, the average analyst consensus on Nufarm is overweight.

Morgan Stanley in particular seems positive on Nufarm's prospects, with the investment bank hitting the company with an overweight rating and a price target of A$7.10 per share.

On today’s share price of A$4.50, such a price target would imply potential upside of around 57%.

Ultimately, Morgan Stanley believes that Nufarm's latest share placement ranks as a key positive. However, the bank looks to be closely watching if Nufarm can effectively execute on its European acquisition agenda, citing poor performance on this front as a key risk.

As always, unfavourable weather conditions also pose a risk to the company's prospects, says Morgan Stanley.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.


Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.